Gene · 6197
Papers2,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities. | Genes Dis | 2024 | 37692481 | PubTator, text mining | PubMed |
| A 6-year-old boy with an atypical liver neoplasm harboring a novel RPS6KA3 variant. | Lab Med | 2024 | 37477894 | PubTator, text mining | PubMed |
| Therapeutic targeting of p90 ribosomal S6 kinase. | Front Cell Dev Biol | 2023 | 38169775 | PubTator, text mining | PubMed |
| The Involvement of Peroxiporins and Antioxidant Transcription Factors in Breast Cancer Therapy Resistance. | Cancers (Basel) | 2023 | 38136293 | PubTator, text mining | PubMed |
| Methylomic, Proteomic, and Metabolomic Correlates of Traffic-Related Air Pollution in the Context of Cardiorespiratory Health: A Systematic Review, Pathway Analysis, and Network Analysis. | Toxics | 2023 | 38133415 | PubTator, text mining | PubMed |
| Genomic Variations Between Fibrolamellar and Conventional Hepatocellular Carcinomas. | Cureus | 2023 | 38116022 | PubTator, text mining | PubMed |
| DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1. | Sci Transl Med | 2023 | 38091406 | PubTator, text mining | PubMed |
| Oral Pyogenic Granuloma: A Narrative Review. | Int J Mol Sci | 2023 | 38069207 | PubTator, text mining | PubMed |
| The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds. | Int J Mol Sci | 2023 | 38069175 | PubTator, text mining | PubMed |
| Hydroxyl Group Acetylation of Quercetin Enhances Intracellular Absorption and Persistence to Upregulate Anticancer Activity in HepG2 Cells. | Int J Mol Sci | 2023 | 38068974 | PubTator, text mining | PubMed |
| A guide to ERK dynamics, part 1: mechanisms and models. | Biochem J | 2023 | 38038974 | PubTator, text mining | PubMed |
| Upregulated PARP1 confers breast cancer resistance to CDK4/6 inhibitors via YB-1 phosphorylation. | Exp Hematol Oncol | 2023 | 38037159 | PubTator, text mining | PubMed |
| Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer. | Front Pharmacol | 2023 | 38026996 | PubTator, text mining | PubMed |
| Regucalcin Is a Potential Regulator in Human Cancer: Aiming to Expand into Cancer Therapy. | Cancers (Basel) | 2023 | 38001749 | PubTator, text mining | PubMed |
| Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis. | Int J Mol Sci | 2023 | 37958993 | PubTator, text mining | PubMed |
| GRF2 Is Crucial for Cone Photoreceptor Viability and Ribbon Synapse Formation in the Mouse Retina. | Cells | 2023 | 37947653 | PubTator, text mining | PubMed |
| Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells. | Cell Death Dis | 2023 | 37938546 | PubTator, text mining | PubMed |
| Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma. | Nat Commun | 2023 | 37932266 | PubTator, text mining | PubMed |
| An unexpected presentation of very severe hypertriglyceridemia in a boy with Coffin-Lowry syndrome: a case report. | BMC Pediatr | 2023 | 37898736 | PubTator, text mining | PubMed |
| Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs. | Pharmaceuticals (Basel) | 2023 | 37895906 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6197/papers?page=5